# Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia

> **NCT02197286** · PHASE2 · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Cholecalciferol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02197286
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-02
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Personnel changes at study site.
- **Last updated:** 2015-10-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02197286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02197286, "Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02197286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*